Inventor
OSTERKAMP FRANK
DE23 patents
⚠️ This page may combine multiple inventors who share the name “OSTERKAMP FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE ORPHAN THERAPIES GMBH
5 patentsUS9169293B2Oct 27, 2015
NPR-B agonists
SHIRE ORPHAN THERAPIES GMBH4 citations81
US9745344B2Aug 29, 2017
NPR-B agonists
SHIRE ORPHAN THERAPIES GMBH3 citations70
US9982016B2May 29, 2018
NPR-B agonists
SHIRE ORPHAN THERAPIES GMBH1 citations60
US9458198B1Oct 4, 2016
Cyclic peptide-based NPR-B agonists
SHIRE ORPHAN THERAPIES GMBH2 citations60
US10196423B2Feb 5, 2019
NPR-B agonists
SHIRE ORPHAN THERAPIES GMBH0 citations48
BAXTER INT
4 patentsUS9018167B2Apr 28, 2015
TFPI inhibitors and methods of use
BAXTER INT3 citations73
US9447147B2Sep 20, 2016
Peptides and methods of use
BAXTER INT3 citations70
US9556230B2Jan 31, 2017
TFPI inhibitors and methods of use
BAXTER INT1 citations62
US8962563B2Feb 24, 2015
TFPI inhibitors and methods of use
BAXTER INT3 citations62
Baxalta GmbH
3 patents3B PHARMACEUTICALS GMBH
3 patentsUS10961199B2Mar 30, 2021
Neurotensin receptor ligands
3B PHARMACEUTICALS GMBH3 citations67
US10799605B2Oct 13, 2020
Conjugate comprising a neurotensin receptor ligand and use thereof
3B PHARMACEUTICALS GMBH3 citations67
US12427210B2Sep 30, 2025
Compounds comprising a fibroblast activation protein ligand and use thereof
3B PHARMACEUTICALS GMBH0 citations53